English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

takayasu arteritis (ta) is a large-vessel vasculitis which affects the aorta and its major branches. steroids are the cornerstone of treatment; however, more than half of the patients relapse, requiring additional immunosuppressive agents. open studies have suggested that methotrexate, cyclophosphamide, azathioprine, mycophenolate mofetil and anti-tnF therapy may be useful in such cases. We conducted a case report of a patient with ta with multiple relapses despite methotrexate, steroids, rituximab, cyclophosphamide, infliximab, percutaneous, and surgical revascularization. Intravenous immunoglobulin (IVIg) was employed, obtaining total and sustained control of vasculitic manifestations, achieving tapering and suspension of steroids as well as diminution of acute phase reactants (Acta Med Colomb 2010; 35: 139-142).

Respuesta a gamaglobulina endovenosa en arteritis de Takayasu de difícil manejo